Rethinking Hepatocellular Carcinoma Surveillance in the MASLD Era

Abstract

Get full access to this article

View all access options for this article.

References

Jaber

Cholankeril

El-Serag

Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies. J Can Assoc Gastroenterol. 2024;7:331-345. doi:10.1093/jcag/jwae025

Mohnasky

Gad

Moon

, et al Hepatocellular carcinoma screening: from current standard of care to future directions. J Am Coll Radiol. 2025;22:260-268. doi:10.1016/j.jacr.2024.10.014

Singal

Llovet

Yarchoan

, et al AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78:1922-1965. doi:10.1097/HEP.0000000000000466

Harris

Hansen

Gray

Massoud

McGuire

Shoreibah

MG.

Hepatocellular carcinoma surveillance: an evidence-based approach. World J Gastroenterol. 2019;25:1550-1559. doi:10.3748/wjg.v25.i13.1550

Maung

Deepan

Decharatanachart

Chaiteerakij

Abbreviated MRI for hepatocellular carcinoma surveillance – a systematic review and meta-analysis. Acad Radiol. 2024;31:3142-3156. doi:10.1016/j.acra.2024.01.028

Woolen

Ahamed

MacDougall

, et al Hepatocellular carcinoma surveillance: operational and environmental impact of abbreviated MRI protocols. Can Assoc Radiol J. Published online September 16, 2025. doi:10.1177/08465371251371567